Related Experiment Video
Updated: May 15, 2026

Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology
Tijana Bojic1, Emina Sudar, Dimitri Mikhailidis
1Institute of Nuclear Sciences Vinča, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Belgrade, Serbia.
Abstract:
In coronary artery disease the G protein related kinases (GRKs) play a role in desensitization of β-adrenoreceptors (AR) after coronary occlusion. Targeted deletion and lowering of cardiac myocyte GRK-2 decreases the risk of post-ischemic heart failure (HF). Studies carried out in humans confirm the role of GRK-2 as a marker for the progression of HF after myocardial infarction (MI). The level of GRK-2 could be an indicator of β-AR blocker efficacy in patients with acute coronary syndrome. Elevated levels of GRK-2 are an early ubiquitous consequence of myocardial injury. In hypertension an increased level of GRK-2 was reported in both animal models and human studies. The role of GRKs in vagally mediated disorders such as vasovagal syncope and atrial fibrillation remains controversial. The role of GRKs in the pathogenesis of neurocardiological diseases provides an insight into the molecular pathogenesis process, opens potential therapeutic options and suggests new directins for scientific research.
Insights
G protein-coupled receptor kinases (GRKs), particularly GRK-2, are implicated in heart failure following myocardial infarction. Lowering GRK-2 levels may reduce heart failure risk and indicate therapeutic efficacy in cardiovascular diseases.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- G protein-coupled receptor kinases (GRKs) are involved in the desensitization of beta-adrenergic receptors (AR) following coronary occlusion.
- Targeted deletion or reduction of cardiac myocyte GRK-2 has been shown to decrease the risk of post-ischemic heart failure (HF).
- Human studies confirm GRK-2 as a marker for HF progression after myocardial infarction (MI).
Purpose of the Study:
- To explore the role of GRKs in cardiovascular diseases, including heart failure and hypertension.
- To investigate GRK-2 as a potential indicator of beta-AR blocker efficacy in acute coronary syndrome.
- To understand the involvement of GRKs in the pathogenesis of neurocardiological disorders.
Main Methods:
- Review of existing studies on GRK involvement in cardiovascular pathophysiology.
- Analysis of human and animal model data regarding GRK levels in various cardiac conditions.
- Exploration of the link between GRKs and therapeutic responses, such as beta-AR blocker efficacy.
Main Results:
- Elevated GRK-2 levels are an early consequence of myocardial injury and are associated with HF progression.
- Increased GRK-2 has been reported in hypertension in both animal models and humans.
- GRK-2 levels may predict beta-AR blocker efficacy in acute coronary syndrome patients.
Conclusions:
- GRK-2 plays a significant role in the pathophysiology of cardiovascular diseases like heart failure and hypertension.
- GRK-2 serves as a potential biomarker for disease progression and therapeutic response.
- Further research into GRKs could reveal new therapeutic strategies for neurocardiological diseases.
More Related Videos
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
GPCR Desensitization
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCRs Regulate Adenylyl Cylase Activity
Two...
G-protein Coupled Receptors

